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Edited by Shou-Wei DingAbstract RNA-dependent transcriptional silencing (RdTS) has
been reported to operate even in human cell lines. It is tempting
to speculate that RdTS plays a role in retroviral gene silencing,
considering that retroviral RNA transcripts harbor a U3 pro-
moter sequence that is a potentially good source of double-
stranded RNAs. To test this possibility, we constructed several
model HeLaS3 cell lines expressing GFP driven by murine leu-
kaemia virus (MLV)-long terminal repeat (LTR) and introduced
a series of shRNAs that target the U3 region of the MLV-LTR.
However, transcriptional gene silencing was not induced in most
instances, in spite of the fact that processed shRNA was found in
cellular nuclei, indicating that RdTS does not contribute to MLV
gene silencing in host cells.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: RNA interference; Gene silencing; Retrovirus;
MLV; siRNA; shRNA1. Introduction
Small RNAs, such as small interfering RNAs (siRNAs) and
microRNAs (miRNAs), function as guide molecules in many
inhibitory pathways that target the transcripts of coding genes
[1–5], a phenomenon known as RNA interference. In this pro-
cess, these tiny RNA species induce either mRNA degradation
or translational repression (post-transcriptional gene silencing
(PTGS)) of mRNAs through speciﬁc base pairing.
In plants, dsRNA molecules that are homologous to a re-
gion of a gene promoter can induce de novo DNA methylation
which results in transcriptional gene silencing (TGS). This phe-
nomenon is termed RNA-dependent DNA methylation
(RdDM) [6,7]. In yeasts, RNAs transcribed from the centro-
meric regions of the genome in both orientations form dsR-
NAs that are processed to siRNAs, which are ﬁnally
embedded in an RNA-induced transcriptional silencing (RITS)Abbreviations: TGS, transcriptional gene silencing; PTGS, post-tran-
scriptional gene silencing; RdTS, RNA-dependent transcriptional
silencing; RISC, RNA induced silencing complex; RITS, RNA
induced transcriptional silencing; MLV, murine leukaemia virus;
LTR, long terminal repeat; FBS, fetal bovine serum
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and induce heterochromatin formation in this region [8,9].
In human cell lines, such as HeLa, several studies have now
reported that the transfection of synthetic siRNAs that target
promoter regions can induce TGS of the corresponding gene
such as EF1A and RASSF1A [10,11]. Since in some cases,
the gene silencing mechanism does not seem to necessarily re-
quire eﬃcient CpG DNA methylation in human cells, it has
been designated as RNA-dependent transcriptional silencing
(RdTS), rather than RdDM [12]. In light of these develop-
ments, it is now important to determine whether these small
regulatory RNAs truly function as transcriptional suppressors
in human cells in a more biologically relevant setting.
Retroviruses initiate the expression of their genomic RNAs
just after integration into the host genome, but this expression
is often suppressed. This repression is known as retroviral gene
silencing and seems to involve a variety of diﬀerent molecular
mechanisms. It is noteworthy in this regard that retroviruses
possess the remarkable characteristic that their RNA tran-
scripts contain a U3 sequence that is homologous to the pro-
moter DNA sequence within the 5 0LTR (long terminal
repeat) region of the provirus. murine leukaemia virus
(MLV) integrates into its host chromosomes in an almost
random manner and it is now well known that there are many
endogenous retroviruses in the genome of its natural hosts. It
is therefore possible to speculate that there would be signiﬁ-
cant opportunities for either exogenous or endogenous
DNA sequences that are homologous to the U3 region of ret-
roviruses to be transcribed from strong promoters of adjacent
host genes in an antisense orientation. The siRNAs produced
from the resulting dsRNA molecules harboring U3 sequences
would then target retroviral RNA transcripts and induce
PTGS. Furthermore, if RdTS is indeed widely operating in
mammalian cells, we can further speculate that such siRNAs
that target U3 promoter sequences would induce retroviral
TGS.
In our present study, we have investigated using MLV-based
expression vectors whether siRNAs play any signiﬁcant role in
the TGS of retroviruses. Because, unlike the mouse genome,
the human genome does not contain signiﬁcant levels of
endogenous retroviruses that are homologous to MLV, we
utilized the human cell line, HeLaS3, in our assay system.
We report a series of expression analyses of the MLV pro-
moter targeted by short hairpin RNAs (shRNAs) that were
expressed from HIV-1-based lentivirus vector in these human
cells.blished by Elsevier B.V. All rights reserved.
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2.1. Plasmid construction
The 0.7-kb BamHI–EcoRI fragment of pCS2-Venus [13], that en-
codes a variant of GFP with improved ﬂuorescence, was inserted into
the BamHI–EcoRI site of pBluescriptII-SK+. The 0.7-kb NotI–EcoRI
fragment of the resultant plasmid was then excised and inserted into
the NotI–EcoRI site of pIRES-Neo (CLONTECH) to generate
pGFP-IRES-Neo-polyA. The 2.1-kb SspI–NotI fragment of pMXs-
IRES-GFP, which is a derivative of a retrovirus vector pMX [14],
was inserted into the NruI–NotI site of pGFP-IRES-Neo-polyA to
generate pMLVLTR-GIN-polyA. The 0.7-kb BamHI–EcoRI frag-
ment of pCS2-Venus was inserted into the BamHI–EcoRI site of
pMXs to generate pMXs-GFP. The 1.8-kb EcoRI–XbaI fragment of
pIRES-Neo was inserted into the EcoRI–XbaI site of pBluescriptII-
SK+ to generate pSK-IRES-Neo. The 1.8-kb NotI–EcoRI fragment
of pSK-IRES-Neo was inserted into the NotI–EcoRI site of pMXs-
GFP to generate pMXs-GIN. For the construction of shRNA expres-
sion lentivirus vector plasmids, a series of oligonucleotide pairs were
synthesized as listed in Supplementary Table S1. Each oligo pair was
annealed and cloned into the pmU6 [15]. Each mU6-shRNA cassette
was then subcloned into the DU3 sequence of the 3 0-LTR in the lenti-
virus vector plasmid.2.2. Cell culture, transfection and cloning
HeLaS3 cells cultured at 37 C in DMEM containing 10% fetal bo-
vine serum (FBS) were seeded at 8 · 105 cells per well in six-well plates.
After 24 h, the cultures were transfected with pMLVLTR-GIN-polyA
(1 lg) using 6 ll Lipofectamine 2000 (Invitrogen) and selected with
G418 (1 mg/ml) from 24 h after the transfection. To establish cellular
clones stably expressing GFP, neomycin resistant cells expressing
GFP were sorted, and single cells were then isolated into 96-well plates,
using FACS Aria (BD). We isolated several stable clones and selected
one of these lines, HeLaS3-LTRGFP#1, which harbors a single copy
of the reporter cassette in its genome for further analysis.2.3. Virus transduction and FACS analysis
HeLaS3-LTRGFP#1 cells were seeded at 1 · 105 cells per well in six-
well plates in DMEM containing 10% FBS and, after 24 h, transduced
with each shRNA expression virus stock (3 · 105 TU) in the presence
of 8 lg/ml of Polybrene. The medium was then changed to DMEM
containing 10% FBS and puromycin (1 lg/ml) after a further 24 h.
After 6 days of selection, the puromycin was removed from the med-
ium. GFP expression levels were measured using FACS Calibur (BD).2.4. Puriﬁcation of nuclear and cytoplasmic small RNAs
Nuclear and cytoplasmic RNA was isolated from untransduced He-
LaS3-LTRGFP#1 cells, or from HeLaS3-LTRGFP#1 cells that were
transduced with a shRNA expression lentivirus vector and grown for
more than one month. Twelve dishes (10 cm in diameter) for each cell
culture were rinsed twice with ice-cold PBS, harvested in a further 2 ml
ice-cold PBS by scraping, and centrifuged for 5 min at 1500 rpm at
4 C. Cell pellets were suspended with NP40 lysis buﬀer [10 mM
Tris–HCl (pH 7.4), 10 mM NaCl, 3 mM MgCl2, 0.5% Nonidet P-
40], incubated on ice for 10 min, and then centrifuged for 5 min at
1500 rpm at 4 C. The cytoplasmic RNA fraction was prepared from
the supernatant by adding ISOGEN (Wako Pure Chemical Industries,
Osaka, Japan). Nuclear pellets underwent two additional washes with
4 ml NP40 lysis buﬀer. RNAs smaller than 200 bp were puriﬁed with
mirVana miRNA Isolation Kit (Ambion, Austin, TX) from puriﬁed
cytoplasmic RNA and nuclear pellets, respectively, according to the
manufacturer’s protocol.
2.5. Northern blot analysis
Ten percent of the total yield of small RNAs from nuclear and cyto-
plasmic fractions was analyzed by Northern blotting to allow for a
comparison with the same cell numbers.
These fractions were separated on denaturing 18% polyacrylamide
gels, transferred to Hybond-XL membranes (Amersham BioSciences)
and crosslinked with 60 mJ/cm2 UV. The synthesized oligonucleotide
probe sequences are listed in Supplementary Table S2 and all probes
were 5 0end-labeled with [a-32P] ATP using T4 polynucleotide kinase
(TAKARA). Hybridizations were performed using Ultrahyb-Oligobuﬀer (Ambion) at 37 C according to manufacturer’s instructions
and membranes were washed using 2·SSC, 0.5% SDS buﬀer. Radioac-
tive signals were visualized using a FLA-5100 (FUJIFILM).
2.6. Quantitative RT-PCR
Seven days after transduction, total cellular RNAs were prepared
with RNeasy Mini kit (QIAGEN) and treated them with DNaseI
(QIAGEN). Quantitative RT-PCR was performed with Superscript
One-Step RT-PCR with Platinum Taq Kit (Invitrogen Corp.). The pri-
mer pairs used to detect mRNA expressions are listed in Supplemen-
tary Table S3. RNA was reverse-transcribed at 50 C for 30 min,
and after an initial denaturation at 94 C for 3 min, cDNA ampliﬁca-
tion procedures were performed as follows: for GFP, 18 cycles of 94 C
for 30 s, 60 C for 1 min, and 72 C for 1 min; for RASSF1A, 26 cycles
of 94 C for 30 s, 56 C for 1 min, and 72 C for 1 min; for GAPDH, 25
cycles of 94 C for 30 s, 58 C for 1 min, and 72 C for 1 min. After
polyacrylamide gel electrophoresis, the band density of the PCR prod-
ucts was quantiﬁed by Densitometry (ATTO Printgraph) using soft-
ware ATTO Densitograph3. Amounts of each cellular RNA were
adjusted so as to give the same band density of PCR products of GAP-
DH.3. Results
3.1. Experimental design and preparation of cell assay systems
As shown schematically in Fig. 1A, mRNA transcribed from
the U3 promoter of a replication-defective MLV-based retrovi-
rus vector, pMXs-GIN, contains a region that is homologous
to the U3 promoter in its 3 0UTR. Since shRNAs that are de-
signed to target U3 promoter DNA regions will also target
such RNA transcripts and cleave them, it is diﬃcult to subse-
quently assay for RdTS of the retroviral promoter using natu-
ral retroviruses, or retroviral vectors derived from them, as
targets. To accurately assay for TGS of the U3 promoter, we
therefore constructed an expression plasmid, pMLVLTR-
GIN-polyA (Fig. 1A), in which, the 3 0-LTR region of
pMXs-GIN has been substituted with the polyadenylation sig-
nal derived from the bovine growth hormone gene. In this set-
ting, shRNAs that target the U3 promoter DNA region would
not suppress GFP expression through PTGS. TGS of the U3
promoter would therefore be detectable by determining the
GFP expression levels. We transfected HeLaS3 cells with this
construct and established six stable clones. Among these, we
identiﬁed a clone, designated HeLaS3-LTRGFP#1, which
was determined to harbour a single copy of the reporter cas-
sette in its genome by Southern blot analysis.3.2. ShRNA expressing lentiviral vectors that target several
regions of the U3 promoter
We designed 12 shRNA species (shU3-1–12) that would tar-
get diﬀerent parts of the U3 promoter region (Fig. 1B). Eight
of these molecules (shU3-1,2,4–9) were designed using guide-
lines previously developed for the selection of highly eﬀective
target sequences [16,17], where antisense RNA (complemen-
tary to the target mRNA) was designed to be selectively assem-
bled into the RNA induced silencing complex (RISC). We
separately introduced 12 diﬀerent pairs of synthetic oligonucle-
otides (Supplementary Table S1) to generate the shRNA
expression cassette, driven by the mouse U6 promoter, which
is present in a self-inactivating HIV-1-based lentivirus vector.
Because the degree of sequence homology between the retrovi-
rus vector and lentivirus vector used here is marginal, we ex-
pected that unintended mutual interactions would be
minimized.
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Fig. 1. (A) Proviral structure of the MLV-based retrovirus vector, pMXs-GIN and structure of the reporter plasmid vector, pMLVLTR-GIN-polyA.
The target region of the shRNAs within the RNA transcript is schematically indicated by the grey bars or under the corresponding DNA sequence.
U3, R and U5 indicate these corresponding sequences from the MLV-LTR; pA, polyadenylation signal; w, packaging signal of the retrovirus vector.
DU3, the U3 sequence from which major enhancer sequences were deleted; R, lentiviral R sequence; U5, lentiviral U5 sequence; w, lentiviral
packaging signal. (B) The DNA sequence of the U3 promoter of the MLV-LTR indicating the speciﬁc regions targeted by the shRNAs. The
transcriptional start site (the ﬁrst nucleotide of the R region) is indicated as +1. Direct repeats are underlined by dotted lines.
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ization of them and their products in HeLaS3 following intro-
duction of two of these shRNAs, shU3-4 and shU3-7. Days
(50–60) after transduction, both nuclear and cytoplasmic
RNA fractions were prepared. In the shRNA producing cells,
unprocessed molecules (56nt) were undetectable in either frac-
tion. As putative guide RNAs, exclusively antisense RNA was
detectable in both shU3-4 and shU3-7 producing cells (Fig. 2),
indicating algorithm used to design these shRNAs worked as
predicted [16,17]. These results also indicate that the process-
ing of shRNA to siRNA and subsequent loading of the speciﬁcR:labeled 24nt RNA
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4:shU
7:shU
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Fig. 2. Analysis of the processing and subcellular localization of RNAs deri
small cytoplasmic RNA and ACA1 small nucleolar RNA served as markerstrand onto RISCs occurs very rapidly. Most importantly,
antisense RNAs originating from either shU3-4 or shU3-7
were present in both the nuclear and cytoplasmic fractions
(Fig. 2). This indicates that shRNA processed by dicer in the
cytoplasm [18] is eﬃciently recruited to the cellular nuclei
and our shRNA expression system is suitable to demonstrate
RdTS.
We next tested whether these shRNAs could eﬃciently de-
grade homologous mRNAs. We transduced pMXs-GIN into
HeLaS3 cells and subsequently obtained a stable GFP express-
ing cell population designated as HeLaS3-ViralGFP. After3-4-transduced
3-7-transduced
N:nucleus
C:cytoplasm
C
7
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Y4 scRNA
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U
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7
ved from transduced and untransduced HeLaS3-LTRGFP#1 cells. Y4
RNAs of cytoplasmic and nuclear fractions, respectively.
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ViralGFP cells and selection with puromycin, the GFP expres-
sion proﬁles were examined. ShRNA that targeted coding re-
gion of the Cre recombinase gene (shCre) was used as
negative control as it has low homology to the U3 sequence.
The results of these experiments showed that each shRNA sup-
pressed exogenous GFP expression. The suppression eﬃciency
was found to be high in most cases, although that of shU3-11
and 12 was not as strong (Fig. 3A).
3.3. The eﬀects of the U3 shRNAs on GFP transcription driven
from the MLV-LTR promoter
The shRNA expression lentivirus vectors were transduced
into HeLaS3-LTRGFP#1 cells, followed by puromycin selec-
tion, and the resulting GFP expression proﬁles were assessed
(Fig. 3B). Eleven out of the 12 shRNAs did not cause any sig-
niﬁcant changes in the GFP expression levels. Only one
shRNA, shU3-7, produced 35% reduction in GFP protein
expression. Using quantitative RT-PCR, we next assessed
GFP mRNA abundance in cells transduced with shU3-7 or
shCre as well as in untransduced cells. The results clearly
showed 38% reduction in GFP mRNA expression speciﬁcally
in shU3-7 transduced cells, indicating that the observed sup-
pression by shU3-7 occurred at the transcriptional level
(Fig. 3C).A B
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Fig. 3. (A) GFP expression levels in HeLaS3-ViralGFP cells expressing the
expression levels were normalized to untransduced HeLaS3-ViralGFP cells. T
of HeLaS3-LTRGFP#1 cells expressing the indicated shRNAs determined
untransduced HeLaS3-LTRGFP#1 cells. The data are expressed as the mean
cells transduced with shU3-7 or shCre (control) as well as those in untransdu
PCR at 7 days post transduction. Simultaneous ampliﬁcation of the GAPDH
RNA analyzed. Obtained signals of GFP mRNA levels were normalized to u
means ± S.E.M.It has been reported in HeLa cells that shRNA molecules in-
duce CpG methylation of homologous DNA at very low fre-
quencies, and it is thus possible that the establishment of
TGS takes some time [11]. We therefore cultured shRNA
transduced HeLaS3-LTRGFP#1 cells for over 1 month and
then determined the GFP expression levels. However, we
found no diﬀerences with the earlier ﬁndings, and the suppres-
sive eﬀects of shU3-7 were also unchanged after more than 7
weeks of culture (Fig. 4A).
In both plants and Drosophila, TGS caused by siRNA is de-
tected in circumstances where PTGS by the same siRNA is
also operating [19,20]. We thus speculated that it might be pos-
sible that the RNA interference eﬀects that we observed in
Fig. 3A would be enhanced in a long-term culture if TGS is
also triggered. We therefore also cultured shRNA transduced
HeLaS3-ViralGFP cells for over 1 month but could detect
no additional suppressive eﬀects upon GFP expression in cells
expressing either shU3-7 or other shRNAs targeting the U3
promoter region (Fig. 4B).
3.4. The eﬀects of shRNA targeting the promoter region of the
endogenous RASSF1A gene
It has been reported that the RASSF1A promoter was CpG
methylated and transcriptionaly suppressed in HeLa cells by
expressing shRNA containing 21-mer sequences complemen-1400 20 40 60 80 100 120
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Fig. 4. Time course of expression levels of GFP in cells producing shRNAs targeting U3 region. (A) GFP expression levels of each shRNA-
transduced HeLaS3-LTRGFP#1 clone were determined at the indicated time points and normalized to untransduced HeLaS3-LTRGFP#1 cells at
the same time point. GFP expression levels of untransduced cells were found to be virtually unchanged (within 10%) during this period. (B) GFP
expression levels of shRNA-transduced HeLaS3-ViralGFP cells, normalized to untransduced cells. GFP expression levels of the untransduced cells
were virtually unchanged (within 10%) during this time range.
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[11,21]. We therefore tested whether our shRNA expression
system induced RdTS on the RASSF1A gene in HeLa cells.
We designed shRASSF1A which targets the same sequence
that caused RdTS in the previous report [11]. The vector car-
rying shRASSF1A expression unit as well as a control vector
expressing shCre was transduced to HeLa cells and abundance
of RASSF1A mRNA in the stably transduced cells was deter-
mined by quantitative RT-PCR. The level of RASSF1A
mRNA in shRASSF1A transduced cells was 97 ± 21% of that
in the shCre transduced cells. According to the previous re-
port, the level of methylation triggered by shRNA targeting
RASSF1A is very low [11]. So we speculate the frequency of
RdTS induced by shRASSF1A would be too low to be de-
tected in the mixed cellular populations transduced with the
shRNA.
3.5. The eﬀects of U3 shRNAs on GFP transcription driven by
the MLV-LTR promoter in non-tumour cells
We next tested whether the results obtained using HeLaS3
cells (Fig. 3B) could be extended to non-tumour cell lines such
as 3Y1 and TIG-3/E/TERT [22]. 3Y1 is a rat ﬁbroblast cell line
with marginal oncogenic potential that does not express any
signiﬁcant MLV-related endogenous viruses. TIG-3/E/TERT
originates from a human diploid embryonic lung ﬁbroblast cell
line, TIG-3, and was immortalized by the introduction of the
hTERT gene. However, TIG-3/E/TERT cells are resistant to
transformation and remain diploid [22]. We transfected these
two cell lines with pMLVLTR-GIN-polyA and prepared two
cellular populations stably expressing GFP, 3Y1-LTRGFP
and TIG-3/E/TERT-LTRGFP.
When a number of our shRNAs were transduced into 3Y1-
LTRGFP cells, very similar eﬀects upon GFP expression were
observed when compared with the HeLaS3-LTRGFP#1 cells,
i.e. most of the shRNAs had no eﬀect on GFP expression,
whereas a slight suppression was observed in cells transduced
with shU3-7 (Supplementary Fig. 2A). We next transduced
some of the U3 shRNAs into the TIG-3/E/TERT-LTRGFP
cells. Among the shRNAs tested, only shU3-7 showed any
cytostatic or cytotoxic eﬀects in these cells and no stable trans-
ductants were obtained. The introduction of other shRNAs
(shU3-3, 4 and 8) showed no eﬀects upon GFP expression in
the TIG-3/E/TERT-LTRGFP cells (Supplementary Fig. 2B).
Considering that shU3-7 showed cytostatic and cytotoxic ef-
fects in TIG-3/E/TERT-LTRGFP cells, shU3-7 would induceoﬀ-target silencing in TIG-3/E/TERT-LTRGFP cells. We
speculate that shU3-7 suppresses unintended mRNA targets
encoding transcription factors or chromatin remodelling fac-
tors which enhance MLV promoter activity, as well as endog-
enous gene transcripts important for cellular proliferation. We
also expect that these eﬀects might also reduce total amounts
of ACA1 snoRNA even in HeLaS3 (Fig. 2).4. Discussion
To test whether TGS is operating as a mechanism for retro-
viral gene silencing, we here stably expressed shRNA targeting
MLV-LTR in cells harboring a GFP reporter gene driven by
MLV-LTR. Our results did not show clear involvement of
TGS in retroviral gene silencing (Figs. 3B and 4A), whereas
the introduced shRNA was successfully processed to the single
stranded guide RNA, which located in both cellular nuclei and
cytoplasm (Fig. 2). These observations are apparently diﬀerent
from previous studies that TGS contributes to gene silencing
of HIV [23,24], which belongs to lentivirus subfamily (Lentivir-
inae) of retrovirus family (Retroviridae). In previous reports,
siRNAs or shRNAs were, in most cases, introduced by direct
transfection of siRNA [23] or transient expression of shRNA
expression plasmids [24], whereas in our system, shRNA were
stably expressed to achieve more physiological conditions. But
in some cases, expression of stable shRNA or even antisense
RNA was shown to suppress HIV-LTR transcription in the
previous work [24]. So the diﬀerence in the methods to express
siRNA would not fully explain this discrepancy and therefore
we could not fully exclude the possibility that our ﬁndings on
MLV might not be directly extended to lentiviruses.
Recently, there have been several reports testing RdTS in
mammals using approaches other than transient siRNA trans-
fection experiments. In dicer-null mouse ES cells, RNA tran-
scripts corresponding to the centromeric major satellite
repeats have been shown to be very much enhanced [25,26].
Other studies of pericentric heterochromatin in these same mu-
tant ES cells, however, have reported contradictory results
showing a partially disrupted [25], or a completely intact re-
gion [26], as judged by DNA methylation and histone H3K9
trimethylation. RdTS pathways have also been reported not
to play any role in the silencing of the transgenic repetitive ele-
ment in baby hamster kidney cells [27]. Our current data and
these earlier ﬁndings thus suggest that the RdTS pathway
4954 T. Haraguchi et al. / FEBS Letters 581 (2007) 4949–4954selectively induces the silencing of a limited region in the gen-
ome such as the centromere, but does not function in a gen-
ome-wide manner in mammalian cells.
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